Free Trial
→ Out of 18,347 Cryptocurrencies... This is the ONLY One (From Crypto 101 Media) (Ad)tc pixel Free LIPO Stock Alerts

Lipella Pharmaceuticals (LIPO) SEC Filings & 10K Form

Lipella Pharmaceuticals logo
$0.51 0.00 (-0.02%)
As of 10/24/2025 11:03 AM Eastern
Compare

Recent Lipella Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
10/21/2025
3:18 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2025
4:00 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2025
11:27 AM		Lipella Pharmaceuticals (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
09/18/2025
7:01 AM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2025
4:07 PM		Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2025
2:14 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
3:25 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
4:05 PM		Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2025
8:19 PM		Huang Leaf (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/14/2025
5:08 AM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
7:39 PM		Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/09/2025
7:43 PM		Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/09/2025
4:06 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
6:16 PM		Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
6:20 PM		Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/07/2025
5:05 AM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
4:14 PM		Lipella Pharmaceuticals (Filer)
Form 424B5
04/03/2025
11:15 PM		Lipella Pharmaceuticals (Filer)
Form EFFECT
03/28/2025
5:21 AM		Lipella Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/27/2025
6:56 PM		Lipella Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2025
5:23 PM		Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/18/2025
4:01 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
7:18 PM		Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/17/2025
7:12 PM		Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:01 PM		Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:09 PM		Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/11/2025
4:26 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
3:05 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:28 AM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
4:32 PM		Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
02/10/2025
4:35 PM		Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/30/2025
4:27 PM		Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/30/2025
4:28 PM		Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
5:08 PM		Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
5:11 PM		Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/17/2025
7:13 PM		Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
7:17 PM		Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/16/2025
5:51 AM		Lipella Pharmaceuticals (Filer)
Form 424B3
01/15/2025
11:15 PM		Lipella Pharmaceuticals (Filer)
Form EFFECT
01/13/2025
7:42 AM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
4:25 PM		Lipella Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/07/2025
4:28 PM		Lipella Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/06/2025
4:25 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
8:22 PM		Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:25 PM		Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
12/30/2024
3:11 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
8:28 PM		Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
8:31 PM		Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
12/27/2024
3:05 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:29 AM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:26 PM		Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
4:01 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:24 PM		Lipella Pharmaceuticals (Filer)
Form PRE 14A
11/01/2024
4:00 PM		Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:LIPO) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners
If You Keep Cash In A U.S. Bank Account… Read This NOW
The Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...
Banyan Hill Publishing | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Move $1,000 into this stock before Nov 6
The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...
Altimetry | Sponsoredtc pixel
Claim Your Share of $5.39 BILLION in AI Equity Checks
The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...
Angel Publishing | Sponsoredtc pixel
$4,200 gold is nice ... but here’s what most gold bugs are missing
Gold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...
Weiss Ratings | Sponsoredtc pixel
Front-Run Buffett's Shocking Gold Move
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsoredtc pixel
Buy UBER immediately
BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...
Chaikin Analytics | Sponsoredtc pixel
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...
Behind the Markets | Sponsoredtc pixel